For example, CD44v6, an alternative CD44 splicing variant containing exon v6, showed markedly increased levels at the late or metastatic stage of gastric and colorectal cancers [90,91], but this CD44 isoform exhibited dramatic reduction in head and neck squamous cell carcinoma [92]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.